[1] National bureau of statistics. China Health Statistical Yearbook [J].Beijing: China statistics press, 2010-2018.
[2] Yip WC, Hsiao WC, Chen W, et al. Early appraisal of China's huge and complex health-care reforms [J]. Lancet, 2012,379(9818): 833-842.
[3] Newhouse JP. Medical-care expenditure: a cross-national survey [J]. J Hum Resour, 1977,12(1): 115-125.
[4] Halici-Tuluce NS, Dogan I, Dumrul C. Is income relevant for health expenditure and economic growth nexus? [J]. Int J Health Econ Manag, 2016,16(1): 23-49.
[5] Harris A, Sharma A. Estimating the future health and aged care expenditure in Australia with changes in morbidity [J]. PLoS One, 2018,13(8): e0201697.
[6] Kocot E. The impact of aging on different types of health care: The example of the Polish health insurance system [J]. Int J Health Plann Manage, 2018,33(2): e557-e568.
[7] Freeland MS, Schendler CE. National health expenditure growth in the 1980's: an aging population, new technologies, and increasing competition [J]. Health Care Financ Rev, 1983,4(3): 1-58.
[8] Zhai T, Goss J, Li J. Main drivers of health expenditure growth in China: a decomposition analysis [J]. BMC Health Serv Res, 2017,17(1): 185.
[9] Gerdtham UG, Sogaard J, Jonsson B, et al. A pooled cross-section analysis of the health care expenditures of the OECD countries [J]. Dev Health Econ Public Policy, 1992,1: 287-310.
[10] Gerdtham UG, Jonsson B, MacFarlan M, et al. The determinants of health expenditure in the OECD countries: a pooled data analysis [J]. Dev Health Econ Public Policy, 1998,6: 113-134.
[11] Okunade AA, Karakus MC, Okeke C. Determinants of health expenditure growth of the OECD countries: jackknife resampling plan estimates [J]. Health Care Manag Sci, 2004,7(3): 173-183.
[12] Herwartz H, Theilen B. Health care and ideology: a reconsideration of political determinants of public healthcare funding in the OECD [J]. Health Econ, 2014,23(2): 225-240.
[13] Wang F. More Health Expenditure, Better Economic Performance? Empirical Evidence From OECD Countries [J]. Inquiry, 2015,52.
[14] Nghiem SH, Connelly LB. Convergence and determinants of health expenditures in OECD countries [J]. Health Econ Rev, 2017,7(1): 29.
[15] Martín JJM, Puerto López del Amo González M, Dolores Cano García M. Review of the literature on the determinants of healthcare expenditure [J]. Applied Economics, 2011,43(1): 19-46.
[16] Herwartz H, Theilen B. The determinants of health care expenditure: testing pooling restrictions in small samples [J]. Health Econ, 2003,12(2): 113-124.
[17] Tan, Xiao. Explaining provincial government health expenditures in China: evidence from panel data 2007–2013 [J]. China Finance & Economic Review,5(1): 9.
[18] WANG Yanshang,LI Huanqing,DU Yue,et al. Research on Forecast of Total Health Expenditure in China and Influencing FactorsBased on Gray Markov Model [J]. Chinese Journal of Social Medicine, 2020,37(01): 89-91.(In Chinese)
[19] Cheng H. WHY PANEL DATA? [J]. Singapore Economic Review, 2012,50(02): 143-154.
[20] McNamara KA, Knox RVLYA, Kim YH, et al. Estimating Distributed Lags in Short Panels with an Application to the Specification of Depreciation Patterns and Capital Stock Constructs [J]. Social Science Electronic Publishing, 1984,51(2): 243-262.
[21] ChengHsiao, Mountain D, KathleenHoIllman. A Bayesian Integration of End-Use Metering and Conditional-Demand Analysis [J]. Journal of Business & Economic Statistics, 1995,13(3): 315-326.
[22] Park BU, Song SH. Comments on: Panel data analysis—advantages and challenges [J]. Test, 2007,16(1): 47-51.
[23] Basile R, Román Mínguez. Advances in Spatial Econometrics: Parametric vs. Semiparametric Spatial Autoregressive Models[M]. The Economy as a Complex Spatial System. 2018.
[24] Meng Q, Yin D, Mills A, et al. China’s encouraging commitment to health [J]. BMJ, 2019.
[25] Yip, W. C., Hsiao, W. C., Chen, W., Hu, S., Ma, J., & Maynard, A. Early appraisal of China's huge and complex health-care reforms[J]. Lancet, 2012,379(9818), 833-842.
[26] Baltagi BH. The Oxford Handbook of Panel Data [J]. Oup Catalogue, 2015,33(1202): 25-26.
[27] Arellano M, Bond S. Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations [J]. Review of Economic Studies, 1991,58(2): 277-297.
[28] Blundell R, Bond S. Initial conditions and moment restrictions in dynamic panel data models [J]. Economics Papers, 1998,87(1): 115-143.
[29] Zeger SL. Longitudinal data analysis using generalized linear models [J]. Biometrika, 1986,42: 121-130.
[30] Vincent C. Working correlation structure misspecification, estimation and covariate design: Implications for generalised estimating equations performance [J]. Biometrika, 2003,90(1): 29-41.
[31] Amiri A, Ventelou B. Granger causality between total expenditure on health and GDP in OECD: Evidence from the Toda–Yamamoto approach [J]. Economics Letters, 2012,116(3): 541-544.
[32] Younsi M, Chakroun M, Nafla A. Robust analysis of the determinants of healthcare expenditure growth: evidence from panel data for low-, middle- and high-income countries [J]. Int J Health Plann Manage, 2016,31(4): 580-601.
[33] Atilgan E, Kilic D, Ertugrul HM. The dynamic relationship between health expenditure and economic growth: is the health-led growth hypothesis valid for Turkey? [J]. Eur J Health Econ, 2017,18(5): 567-574.
[34] Evans, D. B., Elovainio, R., & Humphreys, G. (2010). Health systems financing: The path to uni-versal coverage. Geneva, Switzerland: World Health Organization. Retrieved from: http://www.who.int/whr/2010/whr10_en.pdf?ua D1
[35] Gerdtham UG. The impact of aging on health care expenditure in Sweden [J]. Health Policy, 1993,24(1): 1-8.
[36] Dormont B, Grignon M, Huber H. Health expenditure growth: reassessing the threat of ageing [J]. Health Econ, 2006,15(9): 947-963.
[37] Lopreite M, Mauro M. The effects of population ageing on health care expenditure: A Bayesian VAR analysis using data from Italy [J]. Health Policy, 2017,121(6): 663-674.
[38] TANG Shao-liang, YUAN Jing. Research on influencing factors and structure optimization of provincialhealth costs per capita based on short panel data from 2012 to 2016 [J]. Modern Preventive Medicine, 2019,46(16):2978-2982.(In chinese)
[39] Hyun KR, Kang S, Lee S. Population Aging and Healthcare Expenditure in Korea [J]. Health Econ, 2016,25(10): 1239-1251.
[40] Blakely T, Atkinson J, Kvizhinadze G, et al. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure [J]. N Z Med J, 2014,127(1393): 12-25.
[41] Seshamani M, Gray A. The impact of ageing on expenditures in the National Health Service [J]. Age Ageing, 2002,31(4): 287-294.
[42] Rahman MM, Khanam R, Rahman M. Health care expenditure and health outcome nexus: new evidence from the SAARC-ASEAN region [J]. Global Health, 2018,14(1): 113.
[43] Fujii T. Sources of health financing and health outcomes: A panel data analysis [J]. Health Econ, 2018,27(12): 1996-2015.
[44] Rothberg MB, Cohen J, Lindenauer P, et al. Little evidence of correlation between growth in health care spending and reduced mortality [J]. Health Aff (Millwood), 2010,29(8): 1523-1531.
[45] Lippi G, Mattiuzzi C, Cervellin G. No correlation between health care expenditure and mortality in the European Union [J]. Eur J Intern Med, 2016,32: e13-14.
[46] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. The Lancet, 2019.
[47] Román Mínguez, Roberto Basile, María Durbán. An alternative semiparametric model for spatial panel data [J]. Statistical Methods & Applications, 2019, (82).
[48] Wood. Simon N. Generalized Additive Models: Generalized Additive Models: An Introduction with R, 2 edition [M]. 2007, Chapman & Hall/CRC, Boca Raton, Florida.